Biotech Partners (EIN 943171180) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1993

Legal Domicile

Principal Officer

Lynda Gayden

Phone

5107055192

Tax Period

2024-01-01 to 2024-12-31

Biotech Partners, founded in 1993, is a small nonprofit in the Education sector that reported $698K in total revenue in fiscal year 2024. Revenue fell 58% from the prior year — a significant decline worth monitoring. Expenses of $1.0M exceeded revenue, resulting in a 50% operating deficit.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $721,712

Program Service Revenue $0

Investment Income $0

Other Revenue $-23,818

TOTAL REVENUE $697,894

Expense Breakdown

Grants Paid $0

Salaries & Benefits $589,774

Fundraising Expenses $18,313

Program Expenses $773,468

Other Expenses $459,580

TOTAL EXPENSES $1,049,354

Year-over-Year Comparison

	2024	2023	Change
Revenue	$697,894	$1,658,822	-0.6%
Expenses	$1,049,354	$1,102,639	0.0%
Net Income	$-351,460	$556,183	-1.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

150

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$145,465

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Arjun Natesan PhD	President	8.00	Officer Director	$0	$0	$0
Carla Carriveau JD	Vice President	8.00	Officer Director	$0	$0	$0
Keisha Mitchell MBA MSE BSE	Secretary	8.00	Officer Director	$0	$0	$0
Tobias Schmid PhD	Treasurer	8.00	Officer Director	$0	$0	$0
Elaine Ng PhD	Director	6.00	Director	$0	$0	$0
Kenneth Saffier MD	Director	4.00	Director	$0	$0	$0
Ahmed Akbar BA	Director	3.00	Director	$0	$0	$0
Charles Belle JD	Director	2.00	Director	$0	$0	$0
Roman Urfer PhD	Director	6.00	Director	$0	$0	$0
Steven Feldman PhD	Director	6.00	Director	$0	$0	$0
Lynda Gayden	Executive Director	40.00	Officer	$115,000	$30,465	$145,465

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$697,894	$1,049,354	$992,258	$-351,460
2023	$1,658,822	$1,102,639	$1,264,058	$556,183
2022	$1,316,104	$993,119	$600,687	$322,985
2021	$988,215	$1,082,364	$408,762	$-94,149
2020	$1,133,902	$1,032,996	$923,133	$100,906
2019	$791,200	$694,906	$1,242,191	$96,294
2018	$744,631	$722,946	$259,795	$21,685

Biotech Partners